Sasha King - 08 Jun 2021 Form 4 Insider Report for CareDx, Inc. (CDNA)

Signature
/s/ Peter Maag, as attorney-in-fact for Sasha King
Issuer symbol
CDNA
Transactions as of
08 Jun 2021
Net transactions value
-$73,987
Form type
4
Filing time
09 Jun 2021, 20:30:50 UTC
Previous filing
08 Jun 2021
Next filing
11 Jun 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Options Exercise $15,681 +644 +1.4% $24.35 48,163 08 Jun 2021 Direct F1
transaction CDNA Common Stock Options Exercise $356 +356 +0.74% $1.00* 48,519 08 Jun 2021 Direct F1
transaction CDNA Common Stock Sale $90,024 -1,000 -2.1% $90.02 47,519 08 Jun 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -644 -5.4% $0.000000 11,333 08 Jun 2021 Common Stock 644 $24.35 Direct F1, F3
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -356 -47% $0.000000 394 08 Jun 2021 Common Stock 356 $1.00 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.22, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F3 1/4th of the shares subject to the option vested on January 29, 2021 and 1/48th of the shares subject to the option vest monthly thereafter.
F4 25% of the shares subject to the option vested on March 30, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.